帕金森病中的人工智能:早期检测和诊断进步
Aananya Reddy1, Ruhananhad P Reddy1, Aryan Kia Roghani2
1Department of Internal Medicine, Texas Tech University Health Sciences Center, Lubbock, TX 79430, USA; Lubbock High School, Lubbock, TX 79401, USA.
Ageing research reviews
|July 7, 2024
概括
人工智能 (AI) 和机器学习 (ML) 在早期发现帕金森病 (PD) 方面表现有前途. 这些技术有助于识别生物标志物和开发这种常见的神经退行性疾病的新疗法.
科学领域:
- 神经科学是一个神经科学.
- 计算生物学 计算生物学
- 医学诊断 医学诊断 医学诊断
背景情况:
- 帕金森病 (PD) 是一种流行的神经退行性疾病,其特征是多巴胺能神经元和多巴胺的损失.
- 目前的治疗方法缺乏预防或延缓PD进展的能力,并且仍然需要精确的早期诊断生物标志物.
- 患PD的症状包括运动障碍,如震和缓慢,以及非运动变化.
研究的目的:
- 审查目前对帕金森病流行,发病率和风险因素的理解.
- 讨论现有的诊断生物标志物和帕金森病的治疗策略.
- 突出人工智能 (AI) 和机器学习 (ML) 在PD检测和治疗开发中的新兴作用.
主要方法:
- 对帕金森病流行病学,诊断和治疗现有文献的综述.
- 在评估神经退行性疾病的背景下,探索AI和ML原则,包括神经网络.
- 对AI/ML应用在帕金森病早期检测和治疗干预方面的分析.
主要成果:
- 人工智能和机器学习工具在识别帕金森病早期可检测的标记物方面表现出高准确性.
- 这些计算方法可以帮助诊断疾病的严重程度和寿命.
- 人工智能/ML为开发帕金森病的新型治疗策略和干预措施提供了潜力.
结论:
- 人工智能和机器学习在早期发现和治疗帕金森病方面取得了重大进展.
- 进一步研究和应用这些技术对于改善患者的治疗结果至关重要.
- 将AI/ML整合到临床实践中,有望为彻底改变帕金森病的治疗带来革命.
相关概念视频
01:24Parkinson's Disease: Treatment
251
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
251
01:15Parkinson's Disease: Overview
522
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
522
01:37Neural Regulation
39.3K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.3K
01:21EPS and iPS Cells in Disease Research
2.8K
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
2.8K
01:26Alzheimer's Disease: Overview
461
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
461